Is KLOW Legal? FDA, Compounding and WADA Status
KLOW's FDA status, compounding rules and anti-doping status, with a dated timeline of every change we track.
- FDA status
- Not approved
- unstudied blend
- PCAC vote
- Not reviewed
- not on the Jul 2026 PCAC agenda
- WADA
- Prohibited (S0)
- In and out of competition
Current status
Not FDA approved · unstudied blendNo. KLOW is not FDA approved for any use.
| Country | Status | Source |
|---|---|---|
| United States | Not an approved productNot an approved product anywhere; see components (GHK-Cu, BPC-157, TB-500, KPV). Drugs@FDA (openFDA) search for the component GHK-Cu returned no matches on 2 Oct 2026. | api.fda.govchecked 2 Oct 2026 |
Timeline
Compounding and research-use sellers
- Category 2 is the FDA's list of bulk substances it flagged as raising significant safety concerns. Compounding pharmacies are not expected to compound from them while they are on it.
- The Pharmacy Compounding Advisory Committee (PCAC) advises the FDA on which substances belong on the 503A bulks list that pharmacies may compound from. Its votes are advice; the FDA decides.
- "Research use only" products are sold outside these rules and are not checked by the FDA for identity, purity or dose.
Sport and drug testing
Prohibited by WADA (S0)Contains BPC-157 (named in S0) and TB-500 (S2.3). A blend is prohibited if any component is.
Outside the US
Rules differ by country. KLOW is a pre-mixed blend, not an approved product. Status by country for each ingredient: GHK-Cu, BPC-157, TB-500, KPV.
No regulator record names KLOW; its reported parts are on the agenda
Three of KLOW's four reported components, BPC-157, KPV and TB-500, were on the same July 23 advisory committee agenda for the 503A bulks list.[3]
FDA proposed that BPC-157 (free base) not be included on the 503A Bulks List.[4]
The fourth component, GHK-Cu, follows a different path: non-injectable GHK-Cu will be added back to category 1, with a committee consultation promised before the end of February 2027.[5]
What 503A compounding requires
FDA's 503A page says compounders may use only bulk drug substances that meet a monograph, are components of approved drugs, or appear on the 503A bulks list.[6]
Sport
WADA names BPC-157 in its S0 class of non-approved substances.[1]
WADA also names TB-500, under thymosin beta-4 and its derivatives.[1]
Common questions
Is KLOW FDA approved?
No. FDA's search for GHK-Cu, one of the reported components, returned no matches.[2]
Is KLOW legal to buy?
It is not an approved drug. Online sellers label it "for research use only, not for human use"; the FDA sent warning letters to five such sellers on 24 Aug 2026. Whether a pharmacy may compound it depends on its FDA bulk-substance status. Rules differ by country.
Is KLOW banned by WADA?
Yes. Prohibited by WADA (S0), in and out of competition.
Is KLOW legal?
No record names KLOW. The live regulatory items are the reviews of its reported components, including the FDA proposal against listing BPC-157 (free base).[4]
Is KLOW banned in sport?
If it contains BPC-157 or TB-500, both of which WADA names.[1]
More on KLOW
Sources
- 1World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
- 2United States: Not an approved product anywhere; see components (GHK-Cu, BPC-157, TB-500, KPV). Drugs@FDA (openFDA) search for the component GHK-Cu returned no matches on 2 Oct 2026.U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
- 3Official web pageOfficial web page · web page
- 4Official web pageOfficial web page · web page
- 5Official web pageOfficial web page · web page
- 6Official web pageOfficial web page · web page
Found an error? Report a correction.